Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070557
Filing Date
2025-05-14
Accepted
2025-05-13 17:32:46
Documents
84
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20250331.htm   iXBRL 10-Q 2316119
2 EX-10.1 aplt-ex10_1.htm EX-10.1 109026
3 EX-31.1 aplt-ex31_1.htm EX-31.1 14800
4 EX-31.2 aplt-ex31_2.htm EX-31.2 15230
5 EX-32.1 aplt-ex32_1.htm EX-32.1 9007
6 EX-32.2 aplt-ex32_2.htm EX-32.2 8599
  Complete submission text file 0000950170-25-070557.txt   9513150

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250331.xsd EX-101.SCH 1524051
86 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250331_htm.xml XML 1435714
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 25941707
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)